Latest Articles

Publication Date
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them - Everyday Health

9 Endometrial Cancer Treatment Side Effects, and How to Manage Them Everyday Health

Published: Sept. 9, 2025, 3:15 p.m.
More choice, lower costs and better care for NT women - Department of the Prime Minister and Cabinet

More choice, lower costs and better care for NT women Department of the Prime Minister and Cabinet

Published: Sept. 9, 2025, noon
Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health - Kashmir Age

Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health Kashmir Age

Published: Sept. 9, 2025, 10 a.m.
Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health - Kashmir Despatch

Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health Kashmir Despatch

Published: Sept. 8, 2025, 8:27 a.m.
Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health - Asian Mail

Director SKIMS Calls For Revival of Traditional Practices for Healthy Living, Reaffirms Commitment to Public Health Asian Mail

Published: Sept. 8, 2025, 8:01 a.m.
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study - TipRanks

Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study TipRanks

Published: Sept. 7, 2025, 5:31 p.m.
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States.

Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, and out-of-pocket (OOP) cost, among other …

Published: Sept. 7, 2025, midnight
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks

AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks

Published: Sept. 6, 2025, 4:33 a.m.
Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis.

Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) after laparoscopic surgery. …

Published: Sept. 6, 2025, midnight
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - Medical Xpress

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Medical Xpress

Published: Sept. 5, 2025, 4:10 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!